Tag: inflammation

The landscape of metabolic medicine is undergoing a seismic shift as glucagon-like peptide-1 (GLP-1) receptor agonists and dual agonists redefine the treatment of type 2 diabetes and obesity. However, new research presented at the ENDO 2026 annual meeting suggests that the real-world application of these therapies is far more intermittent than clinical trials initially indicated.…

The Endocrine Society officially released its latest clinical recommendations, titled Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline, during the ENDO 2026 annual meeting in Chicago. The publication marks a significant shift in the medical community’s approach to early onset puberty, advocating for a more nuanced and often more conservative diagnostic process. As pediatric…

The Endocrine Society, the world’s oldest and largest organization devoted to hormone research and the clinical practice of endocrinology, has officially announced the appointment of Nanette Santoro, MD, as its President for the 2026–2027 term. Dr. Santoro, a distinguished physician-scientist currently serving as the E. Stewart Taylor Chair of Obstetrics & Gynecology at the University…

Clinical Leadership and the Human Dimension of Endocrinology A significant component of the evolving endocrine landscape is the professional development of its practitioners. Dr. Milay Luis Lam, MD, Division Chief and Medical Director at Meritus Endocrinology in Hagerstown, Maryland, recently highlighted the transformative impact of leadership programs within the field. Participating in the Endocrine Society’s…

The annual meeting of the Endocrine Society, ENDO 2026, held in Chicago, served as a pivotal stage for the global biotechnology and pharmaceutical industries to unveil transformative data across a spectrum of rare and chronic endocrine disorders. This year’s assembly was characterized by a distinct shift toward oral therapeutic alternatives for conditions traditionally managed by…

The Endocrine Society’s annual meeting, ENDO 2026, has convened in Chicago, Illinois, bringing together thousands of global experts to address the most pressing issues in hormone research and clinical practice. This premier global event serves as a nexus for endocrinologists, researchers, and healthcare professionals to share breakthrough discoveries and establish new standards for patient care.…

The landscape of endocrine medicine has undergone a transformative shift following two major regulatory milestones announced by the U.S. Food and Drug Administration (FDA). In a move that expands the therapeutic options for both autoimmune and metabolic disorders, the FDA has granted accelerated approval to Sanofi’s Tzield (teplizumab-mzwv) for pediatric patients with newly diagnosed Stage…

The upcoming ENDO 2026 conference represents a rare intersection of family legacy and scientific convergence as Dr. Daniel Dumesic of the University of California, Los Angeles (UCLA) and his son, Dr. Phillip Dumesic of the University of California, San Francisco (UCSF), prepare to present research that, while independent, forms a cohesive narrative on metabolic health.…

In a significant recognition of a career dedicated to the intersection of oncology and reproductive biology, Dr. Teresa K. Woodruff has been elected to the Fellowship of the Royal Society and the American Philosophical Society (APS). These appointments place Woodruff among the most elite echelons of the global scientific and intellectual community, acknowledging her pioneering…

The Endocrine Society has officially unveiled a comprehensive modernization of its communication infrastructure, signaling a strategic shift toward digital-first dissemination of medical knowledge to its global membership. In an era where clinical data and therapeutic breakthroughs emerge at an unprecedented pace, the Society is prioritizing the delivery of timely, accurate, and personalized information to empower…